BFC Planning, Inc.’s Coherus Oncology CHRS Stock Holding History

BFC Planning, Inc.’s Portfolio CHRS Stock Details CHRS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$7K	Hold	5,000	–	–	﹤0.01%	2538
2026 Q1	$8.45K	Hold	5,000	–	–	﹤0.01%	2110
2025 Q4	$7.1K	Hold	5,000	–	–	﹤0.01%	2207
2025 Q3	$8.2K	Hold	5,000	–	–	﹤0.01%	2009
2025 Q2	$3.66K	Hold	5,000	–	–	﹤0.01%	2159
2025 Q1	$4.04K	Hold	5,000	–	–	﹤0.01%	2092
2024 Q4	$6.9K	Buy	+5,000	New	+$5.61K	﹤0.01%	1913

Other funds holding CHRS

TGY2IT

Timothy G. Youngquist 2020 Irrevocable Trust Fort Myers, Florida $530M AUM 95.29% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Samsara BioCapital Palo Alto, California $1.22B AUM 242.83% 1-Year Est. Return

Kohlberg Kravis Roberts & Co New York $5.71B AUM 72.37% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

CM Management Gulf Breeze, Florida $157M AUM 60.08% 1-Year Est. Return

C WorldWide Group Copenhagen, Denmark $3.96B AUM 10.41% 1-Year Est. Return

BFC Planning, Inc.'s CHRS Position: Q2 2026 in Review

BFC Planning, Inc. held its Coherus Oncology (CHRS) position steady in Q2 2026 at 5,000 shares worth $7K. The position accounts for ﹤0.01% of the portfolio, ranked #2538.

BFC Planning, Inc. first reported a position in CHRS in Q4 2024 and has held it in 7 quarters since. The position peaked at $8.45K in Q1 2026. 147 funds tracked by Wall St. Rank hold CHRS as of Q2 2026.

BFC Planning, Inc. held 5,000 shares of Coherus Oncology worth $7K as of Q2 2026.
BFC Planning, Inc. left its Coherus Oncology share count unchanged in Q2 2026.
Coherus Oncology made up ﹤0.01% of BFC Planning, Inc.'s portfolio in Q2 2026, its #2538 holding.
BFC Planning, Inc. first reported a position in Coherus Oncology in Q4 2024 and has held it in 7 quarters since.
BFC Planning, Inc.'s Coherus Oncology position peaked at $8.45K in Q1 2026.
147 funds tracked by Wall St. Rank held Coherus Oncology as of Q2 2026.

Based on BFC Planning, Inc.'s 13F filing for Q2 2026, filed 29 Oct 2026.